The CINSARC signature as a prognostic marker for clinical outcome in multiple neoplasms
Abstract We previously reported the CINSARC signature as a prognostic marker for metastatic events in soft tissue sarcomas, breast carcinomas and lymphomas through genomic instability, acting as a major factor for tumor aggressiveness. In this study, we used a published resource to investigate CINSA...
Guardado en:
Autores principales: | Tom Lesluyes, Lucile Delespaul, Jean-Michel Coindre, Frédéric Chibon |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6067c8cad8f243099c0bcfe0a4eac9b9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer
por: Anthony Goncalves, et al.
Publicado: (2021) -
Cell–cell fusion of mesenchymal cells with distinct differentiations triggers genomic and transcriptomic remodelling toward tumour aggressiveness
por: Lucile Delespaul, et al.
Publicado: (2020) -
The prognostic roles of the prognostic nutritional index in patients with intraductal papillary mucinous neoplasm
por: Yukiyasu Okamura, et al.
Publicado: (2021) -
A meta-analysis of Prognostic factor of Pancreatic neuroendocrine neoplasms
por: Yong Gao, et al.
Publicado: (2018) -
Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma
por: Kylee H. Maclachlan, et al.
Publicado: (2021)